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 INTRODUCTION
Contagious bovine pleuropneumonia (CBPP) is an infectious
disease caused by Mycoplasma mycoides mycoides biotype SC
(MmmSC) that is characterized by pleuritis and pneumonia. It is
now one of the most important threat to cattle production in
Africa. Until 1990, the disease seemed to have been under control
in most countries through annual vaccination campaigns.
However, it reappeared recently in countries that were considered
free of the disease. Botswana had remained free of infection for
over fifty years since the disease was eradicated in 1939 from the
Chobe district of the country (9). In 1995, cattle were reported to
be dying in large numbers at Xaudum village, about 70 km from
Mohembo in Northwestern Botswana. Field and laboratory
investigations supported a CBPP diagnosis (1). The government of
Botswana adopted a stamping-out policy which involved the
slaughter of 320,000 cattle from the outbreak zone in Ngamiland
district of Northwestern Botswana. By the end of 1997 about
70,000 cattle had been restocked in the former outbreak zone.
Although a double cordon fence was built on the Namibian border
it is imperative that serosurveillance be carried out in order to
monitor the movement of cattle across the border with Namibia,
from where the disease originally entered Botswana.
Serosurveillance is one of the means that permits the monitoring
of efficient control measures against CBPP. In many infected
countries, CBPP cases are not properly reported because of the
unwillingness of owners to declare the presence of the disease or
of improper control of cattle movements. Therefore, the assess-
ment of CBPP prevalence can be obtained through seromoni-
toring based on a sound sampling frame. The measurement of
CBPP prevalence is the only way to define cost-effective control
strategies or to check that the adopted strategies yield the expected
results. In CBPP free countries, serosurveillance is an additional
tool that allows to check on the status of cattle herds. Serological
testing can also be used for rapid confirmation of new outbreaks in
order to adopt efficient control strategies such as the slaughter of
all animals during an outbreak.
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Summary
The newly developed cELISA for the detection of contagious bovine
pleuropneumonia (CBPP) was applied at the National Veterinary Laboratory,
Gaborone, on a significant number of sera harvested during the epizootics in
1995 and 1998 after complete depopulation of cattle in the outbreak zone.
Results confirmed the excellent specificity of the test with only one serum, out
of 895, from non infected areas having a titer slightly above the cutoff value.
Comparisons with other serological tests such as the complement-fixation test
and the rapid slide-agglutination test on sera collected during the 1995
outbreaks also showed that all three tests have similar sensitivities. The main
advantages of the cELISA reside in its specificity, reproducibility and the
possibility to monitor a quality control program through the use of
internationally developed software such as the ELISA Data Interchange (EDI).
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The serological test that is currently recommended by the Office
international des épizooties (OIE) is the complement-fixation test
(CFT) (2, 8). This test proved to be very useful in the past for
confirmation of CBPP outbreaks and it was extensively used
during the CBPP eradication campaign in Australia or, more
recently, in Italy. It has however some drawbacks. It is difficult to
standardize (3) because of the use of various biological reagents:
antigen batch, sheep red blood cells, thermolabile complement,
etc. It sometimes gives false positive reactions whose origin has
not been clearly elucidated. In the case of a CBPP free country
these false positive reactions are particularly worrisome as they
should normally be followed by field investigations. Moreover,
they sometimes lead to restrictions in cattle imports.
A test based on a competitive ELISA has recently been described
for CBPP (4). It was designed to give a higher specificity through
the use of a monoclonal antibody that is specific to MmmSC. It
was found sensitive enough to detect an antibody rise in
experimentally infected cattle as well as in natural outbreaks. This
test was developed jointly with the International Atomic Energy
Agency (IAEA) in order to be compatible with a uniform ELISA
format used in national reference laboratories throughout Africa. It
is now undergoing a wide field validation both in Europe and
Africa within the framework of an EU DGVIII research grant
devoted to CBPP involving ten countries: Cameroon, Ethiopia,
France, Germany, Kenya, Italy, Namibia, Portugal, Uganda. The
results presented here were obtained through project number
TCP/BOT/6712(A) of the Food and Agriculture Organization
(FAO).
 MATERIALS AND METHODS
Sera
Sera (n = 320) were collected during the CBPP outbreaks in
Northwestern Botswana (Ngamiland District) in 1996. Fifty-five
cattle from infected herds were kept in a government quarantine
station and serially bled weekly until they were finally all
slaughtered according to the stamping-out policy that was
implemented by the Animal Health and Production Department of
Botswana. Sera were stored at -20°C.
Other sera (n = 895) were collected in 1998 from various parts of
the country that had never experienced the disease. They
represented a statistically significant proportion of the cattle
population of Botswana that is free of CBPP.
Complement-fixation test 
The complement-fixation test was carried out in a microplate
format according to the recommended procedure of the OIE (8).
The reagents used were as follows: antigen (Cirad-emvt, France),
complement, hemolytic serum, sheep red blood cells (Biomérieux,
France).
Slide-agglutination test
The slide-agglutination serum test (6, 7) was carried out following
standard procedures, using a methyl violet colored antigen (Cirad-
emvt). Antigen and sera were mixed in equal volumes of 25 µl,
agitated during one minute precisely, a positive reaction being
evidenced by a clear agglutination. A negative control serum was
always run in parallel to ensure the absence of autoagglutination
of the antigen.
cELISA
The test was carried out according to the protocol of Le Goff and
Thiaucourt (4) with slight modifications to ensure compatibility
with the ELISA data interchange (EDI) program of the IAEA.
Briefly, Nunc polysorb plates were coated with a lysed antigen
solution in PBS and incubated overnight at +4°C. One in ten
diluted sera were incubated with the monoclonal antibody for
exactly one hour. The reaction was then revealed by a peroxidase
antimouse conjugate (Dako P260) and an ABTS substrate. The
plates were read at a wavelength of 405 nm after 20 min
incubation when the optical density of the control monoclonal
exceeded 0.8 but was lower than 1.6. The plate reading and
recording were monitored with EDI version 2.1 software of the
IAEA connected to a Multiskan MS reader.
 RESULTS 
cELISA
Reproducibility
This parameter was assessed by comparing the results obtained
with three control sera that were included in each plate (figure 1).
All control titers remained stable throughout the study that
involved two technicians and ten sets of plates. This could be
further evaluated with the distribution of the control results. They
all followed a gaussian curve with: 1) for the high positive control
a mean of 77, acceptable lower control limit (LCL) at 68, upper
control limit (UCL) at 78 (figure 2a); 2) for the low positive
control a mean of 48, LCL at 38, UCL at 58 (figure 2b); and 3)
for the negative control a mean of 10, LCL at 0, UCL at 25
(figure 2c). With these settings for LCL and UCL there was a
single plate that fell outside the limits because of a value below
LCL for the slight positive control.
Another approach to control the reproducibility of the test was to
analyze the distribution of the variation between duplicates. This
value was calculated systematically by the EDI software that
showed the absolute value of the difference between the two
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Figure 1: Values of the three serum controls obtained in ten
consecutive days by two technicians. The lower (LCL) and
upper (UCL) control limits are respectively: C- (0 to 25%), C+
(38 to 48%) and C++ (68 to 78%)
C- = negative control, C+ = intermediate control, C++ = highly
positive control.
Retour au menu
duplicates for each serum. The distribution was obtained by
pooling 400 results from negative and positive sera (figure 3). It
showed a unilateral distribution with only one value above 10,
which is currently considered as the limit that shows that an
individual result is acceptable.
Specificity
The true specificity of the cELISA was evaluated with a
representative sample of Botswana cattle (n = 895) that were
known to be free of CBPP. The distribution of the cELISA results
followed a gaussian (figure 4) curve with a mean of 20.8 and a
standard deviation of 10.3. Only one serum had a cELISA result
above 50 which is the cutoff of this test. It showed that the
specificity of the test approximates 99.9%. It has to be noted
however that the titer of the only serum to exceed the cutoff point
was 50.3, which is in no way comparable to the values obtained
during the outbreak.
Sensitivity
The sensitivity was assessed by analyzing 320 sera from a known
CBPP outbreak. The distribution of the results was strikingly
different from that of the negative population with half of the
results being above the cutoff point (figure 4).
Further comparisons were made on a subset of 48 sera that were
obtained when the animals were slaughtered and necropsied.
Serological results could then be compared with the actual gross
lesions and true sensitivity and specificity could be determined.
Validation d’un ELISA de compétition pour détecter PPCB
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Figure 2: Distribution of the values obtained with the serum
controls at the National Veterinary Laboratory, Gaborone.
Figure 2a: C++ (N = 140); figure 2b: C+ (N = 140); figure 2c: C-
(N = 70)
C- = negative control, C+ = intermediate control, C++ = highly
positive control.
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Figure 3: Distribution of the absolute value of the difference
between duplicates. An individual result is accepted if this
value is less than 10. Here, all but one result were acceptable
and more than 95% had differences below 5.
Figure 4: Distribution of the cELISA results from a negative
population of Botswana in 1998 (N = 895) and distribution of
sera from an epizootic zone in 1995. The cutoff value at 50% is
materialized by a vertical line. All but one negative sera were
below the cutoff point (specificity = 99.9%). Many sera
collected during an outbreak had values above the cutoff.
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Of the 16 animals without lesions, there was complete agreement
between CFT and cELISA with a single animal being positive
(table I). As the same serum was also positive in SAST it can be
assumed that this animal was truly infected. This may be due to a
complete healing of the lesions. SAST seemed less specific as it
detected two other positives, although with slight agglutinations
(rated 1 on a scale of 1 to 4).
Of 32 animals with lesions, CFT and SAST gave 30 positives
(93%) and cELISA 28 (87%) (table II). The slightly lower number
of positives by cELISA could be explained by the fact that these
animals were slaughtered during the acute stage of the outbreak
and therefore were more likely to have high IgM titers which are
complement fixing and agglutinating. It must be noted that the
difference between the three tests is not significant. Agglutinations
with SAST were sometimes weak, which in fact could be
considered as dubious, taking into account that only high positives
would have greatly reduced the sensitivity but improved the
specificity.
 DISCUSSION
The results obtained at the National Veterinary Laboratory show
that this cELISA is a very effective test for CBPP sero-
surveillance. The experience gained on Botswana cattle shows that
the cutoff at 50%, that was primarily set with bovine sera from
different origins, is still valid. It gives a specificity of 99.9%,
which should enable CBPP free countries such as Botswana to
minimize the number of serologically false positive results. The
reduction of this percentage is of great economical importance as
the detection of positives should always be followed by
conservatory control measures such as quarantine and limitation of
animal movements in the suspected area until field investigations
rule out the presence of CBPP. The use of cELISA will certainly
decrease the occurrence of such events.
Good performance in terms of repeatability and user-friendliness
are two of the main advantages of this new serological tool when
compared to CFT. The analysis of numerous plates showed that
the variations between duplicated wells were minimal, normally
less than 10% and less than 6% in 95% of the cases. The analysis
of the variations between duplicates is therefore a good indicator
of the technician’s abilities and should be taken into account for
the acceptance of the results at the individual level (difference less
than 10) or at the plate level. This test requires minimal training as
long as the laboratory has all the facilities to perform ELISA
techniques. The use of uniform protocol and software gives the
opportunity to compare easily the results obtained in various
laboratories.
With the sera analyzed in this study, cELISA had apparently a
slightly lower sensitivity than CFT at the individual level. This
might be due to the presence of IgM that exist at the early stages
of the immune response, these antibodies being complement fixing
but with low affinities. The sensitivity of cELISA is however
expected to compare well with that of CFT, when sera are
collected long after the outbreak as bovine immunoglobulins of
the IgG2 subclass are unable to fix guinea pig complement (5). In
any case, these serological tests for CBPP are to be used at the
herd level and numerous examples have shown that the sensitivity
of both tests was similar with the advantage of the cELISA being
very specific. In the near future, it is expected that cELISA will
permit to assess the real prevalence of CBPP in various regions of
Africa and thus provide accurate information for decision makers
to define the best cost-effective control strategies.
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Table I
Serological results in 16 animals without lesions
CFT cELISA SAST
Positive 1 1 3
Negative 15 15 12
Table II
Serological results in 32 animals with lesions
CFT cELISA SAST
Positive 30 28 30
Negative 2 4 2
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Résumé
Amanfu W., Sediadie S., Masupu K.V., Benkirane A., Geiger R.,
Thiaucourt F. Validation de terrain d’un test ELISA de compé-
tition pour la détection de la péripneumonie contagieuse des
bovins au Botswana
Le test ELISA de compétition, récemment décrit pour détecter
la présence de la péripneumonie, a été utilisé au Laboratoire
national vétérinaire du Botswana à Gaborone. L’échantillon-
nage de sérums a compris un nombre significatif de sérums
récoltés durant l’épizootie de 1995 et ensuite en 1998 après
que la totalité du cheptel bovin de la zone infectée ait été
abattue. Les résultats obtenus ont montré l’excellente spécifi-
cité du test avec un seul sérum négatif, sur 895, ayant un titre
légèrement supérieur au seuil de positivité. La comparaison
avec deux autres tests, la fixation du complément et l’aggluti-
nation sur lame, avec des sérums récoltés durant l’épizootie
de péripneumonie en 1995 a montré que ces trois tests
avaient des sensibilités équivalentes. Les principaux avantages
de l’ELISA de compétition sont sa spécificité, sa reproductibi-
lité et la possibilité qu’il offre de pouvoir effectuer un contrôle
de qualité fiable en étant utilisé avec des logiciels développés
au niveau international comme l’ELISA Data Interchange
(EDI).
Mots-clés : Péripneumonie contagieuse bovine - Mycoplasma
mycoides - Test ELISA - Spécificité - Botswana.
Resumen
Amanfu W., Sediadie S., Masupu K.V., Benkirane A., Geiger R.,
Thiaucourt F. Validación de campo de un test inmuno-
absorbente ligado a una enzima competitiva (cELISA) para la
pleuroneumonía contagiosa bovina en Bostwana
El nuevo cELISA para la pleuroneumonía bovina contagiosa
(CBPP) se aplicó en el Laboratorio Veterinario Nacional, Ga-
borone, en un número significativo de sueros, colectados du-
rante la epizootia de 1995 y 1998, después de la despobla-
ción total de ganado en la zona de la epidemia. Los resulta-
dos confirman la excelente especificidad del test, con
solamente un suero de las áreas no infectadas en 895, presen-
tando un título ligeramente superior al valor límite. Las com-
paraciones con otros tests serológicos, como el test de fijación
de complemento y el test de aglutinación rápida en placa, en
sueros colectados durante las epidemias de 1995, también
mostraron que los tres tests presentan sensitividades compa-
rables. Las principales ventajas del cELISA residen en su espe-
cificidad, reproductibilidad y en la posibilidad de seguir un
programa de control de calidad a través del uso de programas
desarrollados a nivel internacional, como el ELISA Data Inter-
change (EDI).
Palabras clave: Pleuroneumonía contagiosa bovina - Myco-
plasma mycoides - ELISA - Specificidad - Botswana.
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